This is my main concern, at this stage they could offer Canaccord even ++$50M and be miles ahead compared to potentially losing the lot. I'd love to see the numbers but I wouldnt be surprised if they banked half a $B or more in the last couple of years operating this mine, selling the spodumene to themselves on paper thin margins to dodge Australian tax and then make big profits trading it to a processor at spot prices in China... good business.
- Forums
- ASX - By Stock
- A40
- Canaccord Oppose DOCA
Canaccord Oppose DOCA, page-518
Featured News
Add A40 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online